Cronos Group
CRON • NASDAQ
Cronos Group is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Michael Ryan Gorenstein, with a market cap of $966.6M.
Market Cap$966.6M
Employees356.0
CEOMichael Ryan Gorenstein
CountryCanada
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 7, 2026 · In 3 weeksQ1 2026
Financials
CRO
Cronos Group FAQ
Common questions about Cronos Group
Cronos Group is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $51.5M.
Cronos Group has approximately 356 employees.